ALTER-EU Newsletter - 5 - Invitation to ALTER-EU annual assembly on 13-14 October, Combat Monsanto, Earth Open Source

Publication date: 
Wednesday, August 31, 2011
Author: 
ALTER-EU

This fifth newsletter carries news from the ALTER-EU network, with presentations of Combat Monsanto (FR, EN) and Earth Open Source, action alerts from 4 signatories, and an announcement for our assembly, on 13 and 14 October.

Document types: 
 

The Austrian Chamber of Labour - supporter of ALTER-EU - publishes newsletter on lobbying in Europe (in German)

Publication date: 
Monday, September 26, 2011
Author: 
ArbeiterKammer

The Austrian 'Chamber of Labour' - supporter of ALTER-EU - has published a newsletter on lobbying in Europe that features many of the authors and themes of 'Bursting the Brussels Bubble', ALTER-EU's publication. Read it here.

Document types: 
 

ALTER-EU verdict on the new Code of Conduct for MEPs - Significant steps forward to improve transparency but further measures needed to avoid conflicts of interest

Publication date: 
Thursday, July 7, 2011
Press release issued by: 
The Alliance for Lobbying Transparency and Ethics Regulation (ALTER-EU)

ALTER-EU believes that the code of conduct for MEPs that was approved by the Conference of Presidents today is an important step forward to avoid ethics scandals involving MEPs

 

ALTER-EU scorecard on draft Code of Conduct for MEPs - Significant steps forward to improve transparency but further measures needed to avoid conflicts of interest

Publication date: 
Thursday, June 30, 2011
Press release issued by: 
The Alliance for Lobbying Transparency and Ethics Regulation (ALTER-EU)

The new draft Code of Conduct for MEPs is an important step forward, but important measures are needed to prevent conflicts of interest.

 

Joint letter to Commissioner Dalli about the need for safeguards against conflicts of interest in European Medicines Agency (EMA)

Publication date: 
Monday, June 20, 2011

ALTER-EU together with Formindep, HAI Europe and the ISDB write to the Commission regarding the European Medicines Agency’s safeguards conflicts of interest

Document types: 
 

Pages

Subscribe to ALTER-EU RSS